Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study.

Abstract

To determine the risk of uveitis and inflammatory bowel disease (IBD) in patients with psoriatic arthritis (PsA) compared with the general population and patients with psoriasis. A cohort study using data from the UK Clinical Practice Research Datalink between 1998 and 2014. Patients with incident PsA aged 18-89 years were identified and matched to a cohort of patients with psoriasis and a general population cohort. The incidence of uveitis, all IBD, Crohn's disease and ulcerative colitis was calculated for each study cohort and adjusted relative risks (RR_adj) were calculated using conditional Poisson regression. 6783 incident cases of PsA were identified with a median age of 49 years. The risk of uveitis was significantly higher in the PsA cohort than in the general population and psoriasis cohorts (RR_adj 3.55, 95% CI 2.21 to 5.70 and RR_adj 2.13, 95% CI 1.40 to 3.24, respectively). A significant increase was observed for Crohn's disease (RR_adj 2.96, 95% CI 1.46 to 6.00 and RR_adj3.60, 95% CI 1.83 to 7.10) but not for ulcerative colitis (RR_adj1.30, 95% CI 0.66 to 2.56 and RR_adj0.98, 95% CI 0.50 to 1.92). In a primary care-based incidence cohort of patients with PsA, there were substantial risks of developing uveitis and/or Crohn's disease, but not ulcerative colitis, when compared with the general population and psoriasis controls.